Ireland’s decision to prohibit the sale of nicotine pouches and other non-tobacco nicotine products to individuals under the age of 18 represents a proportionate and overdue step to protect children.
GINN is a business association representing small and medium-sized enterprises (SMEs) in the EU that are part of the safer nicotine products value chain. We comply fully with all EU
The STOP/Contre‑Feu narrative and the Tobacco Tactics profile both emphasise that some on the GINN Leadership Team previously worked for or with multinational tobacco companies and then infer a present‑day link
In 2023, Canada approved a tobacco-free oral nicotine pouch, marketed under the name Zonnic, as a nicotine replacement therapy for adult smokers. However, the regulatory framework governing its sale and
This submission is provided on behalf of the Global Institute for Novel Nicotine (GINN), which advocates for proportionate, science-based regulation that recognises tobacco harm reduction (THR) as a legitimate public
Public understanding of nicotine products increasingly depends on how science is communicated through mainstream media. Yet, misinformation and oversimplified reporting continue to influence how adults who smoke, regulators, and health
COP11 has concluded, but the debate around nicotine regulation is far from settled. While delegates left Geneva without adopting aggressive new restrictions, the WHO’s long-standing hostility toward tobacco harm reduction
I’m delighted to welcome María del Carmen Ordóñez López as GINN’s Legal Advisor. María del Carmen brings more than two decades of strategic legal, compliance and governance experience across multinational
Saudi Arabia’s successful Public Health experiment Backed by the Public Investment Fund (PIF), Saudi company Badael has rapidly scaled its harm reduction initiative using its flagship DZRT tobacco-free nicotine pouch.
A recent study published in JAMA Network Open provides important insights into the biological effects of nicotine pouches, adding much-needed clinical evidence to an area often dominated by speculation. The
What a night! Great conversations, new connections, and plenty of collaboration with colleagues from across the nicotine pouch sector. 🗓️ 6:30–9:30 PM, Fri 14 November 📍 Central Stockholm We can’t
At this year’s Food and Drug Law Institute (FDLI) Tobacco and Nicotine Conference, Acting Director for the U.S. Food and Drug Administration’s Center for Tobacco Products (CTP), Dr. Bret Koplow,